Literature DB >> 24993525

Hypoxia-induced tau phosphorylation and memory deficit in rats.

Chang-E Zhang1, Xifei Yang, Lingyun Li, Xiaojing Sui, Qing Tian, Wei Wei, Jianzhi Wang, Gongping Liu.   

Abstract

Hypoxia was shown to be associated with an increased risk of Alzheimer's disease (AD). The effects of hypoxia on the development of AD pathology and spatial memory ability and the possible molecular mechanisms remain poorly understood. In this study, we demonstrate that rats exposed to a hypoxic condition (10% oxygen concentration) for 1, 2, 4 and 8 weeks (6 h each day) displayed spatial memory impairment and increased tau phosphorylation at Ser198/199/202, Thr205, Ser262, Ser396 and Ser404 in the hippocampus. Concomitantly, the levels of Tyr216-phosphorylated glycogen synthase kinase (GSK)-3β (activated form of GSK-3β) and Tyr307-phosphorylated protein phosphatase 2A (inactivated form of PP2A) were significantly increased in the hippocampus of the rats with 1, 2, 4 and 8 weeks of hypoxia exposure, while the levels of methylated PP2A (activated form of PP2A) were significantly decreased in the hippocampus of the rats with 4 and 8 weeks of hypoxia exposure. In addition, the content of malondialdehyde, an indicator of oxidative stress, was elevated, whereas the activity of superoxide dismutase was not significantly changed in the hippocampus of the rats exposed to hypoxia. Taken together, these data demonstrated that hypoxia induced tau hyperphosphorylation and memory impairment in rats, and that the increased tau phosphorylation could be attributed to activation of GSK-3β and inactivation of PP2A. These data suggest that interventions to improve hypoxia may be helpful to prevent the development of AD pathology and cognitive impairment.
© 2014 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24993525     DOI: 10.1159/000362239

Source DB:  PubMed          Journal:  Neurodegener Dis        ISSN: 1660-2854            Impact factor:   2.977


  18 in total

1.  Reduced deep regional cerebral venous oxygen saturation in hemodialysis patients using quantitative susceptibility mapping.

Authors:  Chao Chai; Saifeng Liu; Linlin Fan; Lei Liu; Jinping Li; Chao Zuo; Tianyi Qian; E Mark Haacke; Wen Shen; Shuang Xia
Journal:  Metab Brain Dis       Date:  2017-12-16       Impact factor: 3.584

Review 2.  Amyloid beta modulators and neuroprotection in Alzheimer's disease: a critical appraisal.

Authors:  Chandra Sekhar Kuruva; P Hemachandra Reddy
Journal:  Drug Discov Today       Date:  2016-10-27       Impact factor: 7.851

Review 3.  Brain Under Stress and Alzheimer's Disease.

Authors:  Boris Mravec; Lubica Horvathova; Alexandra Padova
Journal:  Cell Mol Neurobiol       Date:  2017-07-11       Impact factor: 5.046

Review 4.  Functional analyses of major cancer-related signaling pathways in Alzheimer's disease etiology.

Authors:  Jianping Guo; Ji Cheng; Brian J North; Wenyi Wei
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2017-07-08       Impact factor: 10.680

Review 5.  Role of microtubule-associated protein tau phosphorylation in Alzheimer's disease.

Authors:  Rong-Hong Ma; Yao Zhang; Xiao-Yue Hong; Jun-Fei Zhang; Jian-Zhi Wang; Gong-Ping Liu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2017-06-06

Review 6.  Oxygen Sensing and Signaling in Alzheimer's Disease: A Breathtaking Story!

Authors:  Sónia C Correia; Paula I Moreira
Journal:  Cell Mol Neurobiol       Date:  2021-09-12       Impact factor: 5.046

7.  PROTACs technology for treatment of Alzheimer's disease: Advances and perspectives.

Authors:  Hiroyuki Inuzuka; Jing Liu; Wenyi Wei; Abdol-Hossein Rezaeian
Journal:  Acta Mater Med       Date:  2022-01-21

Review 8.  The neuroprotective effects of oxygen therapy in Alzheimer's disease: a narrative review.

Authors:  Cui Yang; Qiu Yang; Yang Xiang; Xian-Rong Zeng; Jun Xiao; Wei-Dong Le
Journal:  Neural Regen Res       Date:  2023-01       Impact factor: 6.058

9.  Comparison of serum neurodegenerative biomarkers among hospitalized COVID-19 patients versus non-COVID subjects with normal cognition, mild cognitive impairment, or Alzheimer's dementia.

Authors:  Jennifer A Frontera; Allal Boutajangout; Arjun V Masurkar; Rebecca A Betensky; Yulin Ge; Alok Vedvyas; Ludovic Debure; Andre Moreira; Ariane Lewis; Joshua Huang; Sujata Thawani; Laura Balcer; Steven Galetta; Thomas Wisniewski
Journal:  Alzheimers Dement       Date:  2022-01-13       Impact factor: 16.655

Review 10.  Biomarkers of dementia in obstructive sleep apnea.

Authors:  Andrée-Ann Baril; Julie Carrier; Alexandre Lafrenière; Simon Warby; Judes Poirier; Ricardo S Osorio; Najib Ayas; Marie-Pierre Dubé; Dominique Petit; Nadia Gosselin
Journal:  Sleep Med Rev       Date:  2018-08-13       Impact factor: 11.609

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.